Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is proud to announce the launch of its D
The Nobel Prize in Physiology or Medicine awarded
This year, the Hamburg based life sciences company
Alembic Pharmaceuticals Ltd., t
Since it’s an ingredient in so many foods, you h
Dear Readers,Welcome to the latest issue of Microb
China will purchase COVID-19 vaccines for just 1 percent of its population, or 15 million people, via a global scheme backed by the World Health Organization, the Foreign Ministry said on Friday.
Beijing’s move to join the COVAX programme means China”will be procuring vaccines through the facility for a percentage of their own population, just as with other nations”, a spokesman for GAVI, which co-leads the strategy, said earlier.
The first batch of vaccine available under the program will be in short supply, so there would be less for other countries if China had secured doses for a large number of its 1.4 billion people, ministry spokeswoman Hua Chunying told a news briefing.
China has four experimental vaccines in final stages of clinical trials, and is also in discussions with the WHO to have its domestically made vaccines assessed for global use.
Self-financing countries in COVAX scheme can request vaccine doses sufficient for 10-50 percent of the populations, GAVI said on its site.
Funded countries will receive enough doses to vaccinate around 20 percent of the population in the longer term, GAVI said.
